What Kind of Life Sciences Data and Coverage Does Biotechgate Provide?

Updated

Biotechgate provides structured life sciences data across six main categories: company profiles, management contacts, licensing-ready assets, clinical trials, analyst reports and financial models, and license agreements. According to the platform's own coverage figures, this includes 70K+ company profiles, 385K+ management contacts, 42K+ licensing-ready assets, 1M+ clinical trials, 250K+ reports and forecast models, and 48K+ license agreements. If your question is whether Biotechgate covers a specific company, asset, trial, deal, or contact, the answer depends on which of these six categories your target falls into — and the platform is designed so those categories connect to each other rather than sitting in separate silos.

The Six Data Categories and What Each Contains

Data type Reported scale What it covers
Company profiles 70K+ Global life sciences companies with structured business and pipeline data
Management contacts 385K+ Executive and functional contacts for outreach, qualification, and partnering
Licensing-ready assets 42K+ Assets and technologies with development phase, indication, and licensing status
Clinical trials 1M+ Trial activity supporting pipeline, competitor, and market analysis
Reports & forecast models 250K+ Curated analyst reports and financial models for research, valuation, and due diligence
License agreements 48K+ Deal terms, territories, payment structures, and original contract details

Each category answers a different question. Company profiles tell you who a company is and what its pipeline looks like. Management contacts tell you who to reach. Licensing-ready assets tell you what is available to license and at what stage. Clinical trials tell you what is being tested and by whom. Reports and models support valuation and diligence work. License agreements show how comparable deals were structured.

How the Data Connects

The more useful characteristic is that these categories are linked. Biotechgate describes its intelligence layer as connecting "curated company, asset, clinical, financial, deal and contact data" into one structured foundation. In practice, that means a search can move across categories — for example, from a company to its assets, then to the trials those assets are in, then to the licensing status and related deal terms, without manually stitching sources together.

This matters most for BD&L (business development and licensing) work, where the relevant question is rarely confined to one data type. Identifying a licensing opportunity typically requires a company, an asset, a development phase, a territory, and a contact — all of which sit in different categories above.

Where the Data Comes From

Biotechgate states that its platform combines "expert human curation with AI-driven intelligence." The research content — analyst reports and financial models — is described as human-curated, while the search and research workflows are AI-guided. The structured data (companies, assets, trials, deals, contacts) forms the foundation those workflows operate on.

This distinction is worth noting if data provenance matters to your use case: the platform positions curated research content as sourced, and the AI layer as a way to query it rather than a replacement for it.

How This Coverage Is Accessed

The coverage above is delivered through two AI-guided workflows:

  • BD&L Intelligence — search in plain language across companies, assets, licensing opportunities, deals, trials, financing rounds, management contacts, and partnering interests. The platform translates a natural-language query into structured results, so no query language is required.
  • AI Research Workspace — ask questions across curated analyst reports and financial models to support due diligence, valuation, pipeline assessment, and market research.

A free trial is referenced on the site ("Try for free"), and a demo can be requested. Specific pricing, seat limits, and access terms are not stated in the available material, so confirm those directly with Biotechgate before assuming a particular plan or usage level.

Deciding Whether the Coverage Fits Your Need

Use the six categories as a checklist against your actual task:

  • If you need to find and qualify partners or licensing targets, the company, asset, contact, and deal categories are the relevant ones.
  • If you need pipeline or competitor analysis, clinical trials plus company pipeline data are the core.
  • If you need valuation or diligence support, the reports and forecast models category is where that sits.
  • If you need deal precedent — terms, territories, payment structures — the license agreements category is the match.

If your target data type is not among these six, Biotechgate's stated coverage does not address it. If it is, the next step is to verify depth for your specific therapeutic area or geography, since the headline figures are totals and do not guarantee coverage of any individual company or asset.